FOXP3 Genetic Variation at Position -2383 C/T (rs3761549) in Patients with Breast Cancer

被引:0
|
作者
Shiri, Zahra [1 ]
Mansouri, Reza [1 ,2 ]
Haghshenas, Mohammad Reza [3 ]
Talei, Abdolrasoul [4 ,5 ]
Erfani, Nasrollah [3 ,6 ]
机构
[1] Shahid Sadoughi Univ Med Sci, Int Branch, Fac Med, Dept Immunol, Yazd, Iran
[2] Shahid Sadoughi Univ Med Sci, Hematol & Oncol Res Ctr, Yazd, Iran
[3] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Shiraz, Iran
[4] Shiraz Univ Med Sci, Breast Dis Res Ctr, Shiraz, Iran
[5] Shiraz Univ Med Sci, Sch Med, Dept Surg, Shiraz, Iran
[6] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran
关键词
Breast cancer; FOXP3; gene; Single nucleotide polymorphism; PCR-RFLP; RISK-FACTORS; T-CELLS; POLYMORPHISMS; EPIDEMIOLOGY; WOMEN; IPEX;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the possibility of an association between the C-2383T polymorphism (rs3761549) in the promoter region of the FOXP3 gene with breast cancer. Methods: The study groups consisted of 250 women diagnosed with breast cancer (case group) and 250 healthy women (control group). Polymerase chain reaction-restriction fragment length polymorphism was performed for genotyping. Results: Breast cancer cases had a C allele frequency of 455 (91%) and T allele frequency of 45 (9%). The control group had a C allele frequency of 468 (93.6%) and 32 (6.4%) for the T allele. The CC genotype was present in 206 (82.4%) patients, 43 (17.2%) patients had the CT genotype, and the TT genotype was observed in 1 (0.4%) patient. In the control group, 219 (87.6%) had the CC genotype, whereas 30 (12%) had the CT genotype, and 1 (0.4%) had the TT genotype. Statistical analysis revealed no significant differences in the distribution of alleles and genotypes between patients and controls (P>0.05). There was no significant association between genotype distribution and patients' clinicopathological factors. Conclusion: Our results do not support an association between the FOXP3 -2383 C/T polymorphism and breast cancer in a population from southern Iran.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 50 条
  • [21] Heterozygous Genetic Variations of FOXP3 in Xp11.23 Elevate Breast Cancer Risk in Chinese Population via Skewed X-Chromosome Inactivation
    Zheng, Jian
    Deng, Jieqiong
    Jiang, Lan
    Yang, Lei
    You, Yonghe
    Hu, Min
    Li, Na
    Wu, Hongchun
    Li, Wei
    Li, Hongbin
    Lu, Jiachun
    Zhou, Yifeng
    HUMAN MUTATION, 2013, 34 (04) : 619 - 628
  • [22] Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy
    Tsiatas, Marinos
    Kalogeras, Konstantine T.
    Manousou, Kyriaki
    Wirtz, Ralph M.
    Gogas, Helen
    Veltrup, Elke
    Zagouri, Flora
    Lazaridis, Georgios
    Koutras, Angelos
    Christodoulou, Christos
    Pentheroudakis, George
    Petraki, Constantina
    Bafaloukos, Dimitrios
    Pectasides, Dimitrios
    Kosmidis, Paris
    Samantas, Epaminontas
    Karanikiotis, Charisios
    Papakostas, Pavlos
    Dimopoulos, Meletios-Athanassios
    Fountzilas, George
    CANCER MEDICINE, 2018, 7 (10): : 5066 - 5082
  • [23] FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
    Ladoire, S.
    Mignot, G.
    Dalban, C.
    Chevriaux, A.
    Arnould, L.
    Rebe, C.
    Apetoh, L.
    Boidot, R.
    Penault-Llorca, F.
    Fumoleau, P.
    Roche, H.
    Spielmann, M.
    Levy, C.
    Lortholary, A.
    Eichler, F.
    Mesleard, C.
    Bonnetain, F.
    Ghiringhelli, F.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2552 - 2561
  • [24] Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
    Sylvain Ladoire
    Laurent Arnould
    Grégoire Mignot
    Bruno Coudert
    Cédric Rébé
    Fanny Chalmin
    Julie Vincent
    Mélanie Bruchard
    Bruno Chauffert
    François Martin
    Pierre Fumoleau
    François Ghiringhelli
    Breast Cancer Research and Treatment, 2011, 125 : 65 - 72
  • [25] Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy
    Ladoire, Sylvain
    Arnould, Laurent
    Mignot, Gregoire
    Coudert, Bruno
    Rebe, Cedric
    Chalmin, Fanny
    Vincent, Julie
    Bruchard, Melanie
    Chauffert, Bruno
    Martin, Francois
    Fumoleau, Pierre
    Ghiringhelli, Francois
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 65 - 72
  • [26] PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients
    Makrantonakis, Andreas-Evangelos
    Zografos, Eleni
    Gazouli, Maria
    Dimitrakakis, Konstantinos
    Toutouzas, Konstantinos G.
    Zografos, Constantinos G.
    Kalapanida, Despoina
    Tsiakou, Andriani
    Samelis, George
    Zagouri, Flora
    MEDICINA-LITHUANIA, 2022, 58 (10):
  • [27] The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
    Noriko Goda
    Shinsuke Sasada
    Hideo Shigematsu
    Norio Masumoto
    Koji Arihiro
    Hiroyoshi Nishikawa
    Shimon Sakaguchi
    Morihito Okada
    Takayuki Kadoya
    Discover Oncology, 13
  • [28] Investigating the association of rs920778T > C polymorphism in HOTAIR gene in breast cancer patients in the northwestern of Iran
    Shavali, Mojtaba
    Pouladi, Nasser
    Abdolahi, Sepher
    Farajzadeh, Davoud
    Moniri, Solmaz
    META GENE, 2020, 25
  • [29] HIF1A C1772T genetic variation is associated with the elevated risk of breast cancer among Asians: An updated meta-analysis
    Kancharla, Jyothsna
    Dariya, Begum
    Momin, Saimila
    Prasad, Immadisetty Devi Vara
    Bhaskar, L. V. K. S.
    Bramhachari, Pallaval Veera
    Alam, Afroz
    META GENE, 2020, 25
  • [30] Prognostic value of tumor-infiltrating Foxp3+regulatory T cells in patients with breast cancer: a meta-analysis
    Zhou, Yu
    Shao, Nan
    Aierken, Nijiati
    Xie, Chuanbo
    Ye, Runyi
    Qian, Xueke
    Hu, Ziye
    Zhang, Jin
    Lin, Ying
    JOURNAL OF CANCER, 2017, 8 (19): : 4098 - 4105